TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04569760

Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study

Cause of deathFunding or business Automatic label, confidence 0.5, unverified. How labels are made.
“Project cancelled prior to commencing recruitment”

The sponsor’s own words in the registry.

Life of this trial

202020212022Registered2020-09-24Withdrawn (as of)2021-03-24Planned start2021-04 (planned)

Vital statistics

Status
Withdrawn
Phase
Phase 3
Sponsor
McMaster University
Sponsor type
University, hospital or other
Conditions
Generalized Anxiety Disorder; Social Anxiety Disorder; Panic Disorder; Agoraphobia
Interventions
50:2 mg(CBD:THC)/ml - Cannabinoid Oil Oral Preparation- titrated as tolerated up to a maximum 8mls twice daily (200 mg- 800 mg total dose); Placebo Oil
Participants
0
Sites
1
Countries
Canada

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.